Yes, asthma is a chronic lung disease. It is a long-term condition affecting the airways in the lungs, characterized by inflammation that causes those airways to narrow and make breathing difficult. An estimated 363 million people worldwide had asthma in 2023, and the condition caused 442,000 deaths that year.
While asthma symptoms come and go in episodes, the underlying disease persists over time. This is what makes it chronic rather than acute: even when you feel fine between flare-ups, the potential for airway inflammation and narrowing remains.
What Happens in Your Airways
Your airways are the tubes that carry air in and out of your lungs. In asthma, these tubes become inflamed and swollen, which narrows the space air has to pass through. At the same time, the muscles wrapped around the airways can tighten suddenly (a process called bronchoconstriction), and the airway lining can produce excess mucus. All three of these changes work together to make it harder to breathe, especially when exhaling.
In roughly half of people with asthma, this inflammation is driven by a specific branch of the immune system that produces certain signaling molecules. These molecules trigger a chain reaction: they attract a type of white blood cell called eosinophils into the airways, ramp up mucus production, and make the airways hypersensitive to triggers like allergens, cold air, or exercise. This form is sometimes called “type 2-high” asthma, and it tends to respond well to standard inhaled treatments.
The other half of asthma cases don’t follow this pattern. This “type 2-low” asthma is more commonly associated with obesity and involves different immune cells called neutrophils. It also tends to be less responsive to the corticosteroid inhalers that are the backbone of most asthma treatment, which makes it trickier to manage.
How Asthma Differs From COPD
Asthma and chronic obstructive pulmonary disease (COPD) are both chronic lung diseases, and they can look similar on the surface. Both cause shortness of breath, wheezing, and coughing. The key difference lies in whether airway narrowing is reversible.
In asthma, the obstruction reverses. When you use a bronchodilator (a medication that relaxes the airway muscles), lung function improves by at least 12% on a breathing test. In COPD, the obstruction is largely fixed. Bronchodilators provide some relief, but the airway narrowing doesn’t bounce back in the same measurable way. COPD is also almost always linked to long-term smoking or other sustained lung damage, while asthma often begins in childhood and frequently has allergic roots.
Some people have features of both conditions, a situation doctors call asthma-COPD overlap. In these cases, breathing tests show the reversibility typical of asthma alongside a persistent baseline limitation that looks more like COPD.
How Asthma Is Diagnosed
Diagnosis centers on a breathing test called spirometry, where you blow as hard and fast as you can into a device that measures how much air you can push out and how quickly. The test is done before and after inhaling a bronchodilator. If your lung function improves by at least 12% and at least 200 milliliters after the medication, that reversibility points strongly toward asthma.
When spirometry results are borderline or normal (asthma symptoms can be absent on a good day), doctors sometimes use a challenge test. You inhale a substance that deliberately irritates the airways, and if your lung function drops by 20% or more at a low dose, that hypersensitivity is consistent with asthma. Peak flow monitoring, where you use a small handheld device at home to track airflow over days or weeks, can also help. Variability of 20% or more in peak flow readings suggests asthma.
What Happens to Your Lungs Over Time
Because asthma is chronic, years of repeated inflammation can physically change the airways in a process called airway remodeling. The walls of the airways thicken. The basement membrane (a thin layer beneath the surface lining) becomes denser. The smooth muscle around the airways grows in bulk, which means it can squeeze the airway more forcefully during a flare. These structural changes can make the airways permanently narrower over time, even between episodes.
Remodeling is a significant reason why early and consistent treatment matters. It doesn’t happen overnight, but poorly controlled asthma over years allows chronic inflammation to steadily alter airway architecture. Once these changes set in, airway narrowing becomes less reversible, and the condition starts to behave more like COPD. Well-managed asthma, on the other hand, slows or limits this process considerably.
How Asthma Is Managed Long-Term
Current guidelines from the Global Initiative for Asthma (GINA) have shifted the approach to treatment in an important way: using a short-acting rescue inhaler alone is no longer recommended as the starting point for mild asthma. That strategy, once standard, is now linked to increased risks of severe flare-ups and asthma-related deaths.
Instead, the preferred approach pairs a low-dose anti-inflammatory inhaler with a fast-acting bronchodilator in a single device. You use this combination both as your daily maintenance treatment and as your rescue inhaler when symptoms break through. This “maintenance and reliever” strategy has been shown to reduce severe exacerbations more effectively than older approaches that used separate inhalers for daily use and emergencies.
For people who prefer a different regimen, an alternative track uses a low-dose anti-inflammatory inhaler on an as-needed basis alongside a traditional rescue inhaler. If asthma remains poorly controlled on either approach, treatment steps up to higher doses or additional medications. The goal at every stage is the same: keep inflammation low enough to prevent the airway damage and dangerous flare-ups that define uncontrolled chronic asthma.
Most people with asthma can live with minimal symptoms and few limitations on physical activity when treatment is consistent. The chronic nature of the disease means it requires ongoing attention, not a one-time fix, but the tools available today are effective enough that well-controlled asthma rarely interferes with daily life.